BioMap

If you’re attending ICML 2024, don’t forget to sign up for the ‘AI for Science - Scaling in AI for Scientific Discovery’ workshop on July 26th, 9:00 a.m. - 5:00 p.m. CEST. Le Song, CTO at BioMap, will be presenting our paper: “Training Compute-Optimal Protein Language Models”. Through extensive training of more than 300 models, this research has uncovered important insights into how model size, training data, and performance are interconnected. Secure your place at the workshop here: https://buff.ly/3S4WPbb #MachineLearning #ML #AI #ArtificialIntelligence #Science #Technology #Innovation #BioMap #ICML

Have you applied to the BioMap BioX program yet? In line with our dedication to fostering tech innovation and accelerating the bio-computing ecosystem globally, BioMap has launched the BioX initiative to accelerate global life sciences development with AI. The program is designed to support the transformation of early-stage R&D into market-ready products and industrialized companies, focusing on pharmaceuticals and health, green technology, industrial innovation, and consumer product innovation. Benefits for successful applicants: - Access to BioMap’s AIGP platform with credits worth over $200,000 - Assistance in connecting with international companies and demand side entities - Access to professional AI, biology, and IT experts, as well as training programs tailored to the needs of startup projects - Access to InnoX's network of signed investors, with investment funds available for evaluated startup projects Submit your application here: https://buff.ly/3VS90sU

BioMap and Porton Advanced have joined forces to usher in a new era of gene therapy with AI-powered adeno-associated virus (AAV) solutions! 🧬   This groundbreaking partnership leverages BioMap's cutting-edge AI models (xTrimoPGLM) with Porton Advanced's expertise in AAV development.   Together, we're revolutionizing AAV vector design, offering: - Innovative AAV library design service: Over 10 serotypes, enhanced transduction efficiency, tissue specificity & immune evasion. - Industry-leading xTrimoAAVViability v1.0 model: Predicts AAV viability with unmatched accuracy, accelerating vector development. - Bespoke AI design services: Tailored model fine-tuning for personalized needs.   This collaboration unlocks new possibilities in gene therapy research! 🔬   Ready to join us in pioneering the future?   Contact us at info@biomap.com to explore how BioMap's AI expertise and Porton Advanced's experience can accelerate your gene therapy project.   #genetherapy #AAV #AI #biotech #partnership #innovation #ArtificialIntelligence #technology Porton Advanced │ Cell & Gene Therapy CDMO/CRO

Don’t forget to apply to the BioMap BioX program! Targeting four key areas — pharmaceuticals and health, green technology, industrial innovation, and consumer product innovation — BioMap will select and support teams from universities and startups, providing technical support and facilitating connections with global companies and investors in the life sciences and bio-computing sectors. Whether you are: - a cutting-edge life sciences researcher exploring the underlying mechanisms of biology through protein perturbations - a protein industry scientist designing new protein products - a drug discovery scientist solving large molecule design challenges with new technologies - or an innovative young entrepreneur using AI to change the world We welcome you to join the initiative! Don’t miss the opportunity to take advantage of BioMap’s 100-Billion parameter large protein language model and platform ecosystem capabilities to support your transition from early-stage research to marketable products and industrial-scale companies. Apply now: https://buff.ly/3VS90sU

BioMap will be attending the International Conference on Machine Learning (ICML) 2024 in Vienna from July 21st-26th. 🇦🇹 We’re looking forward to coming together with academic and industry peers to explore the latest advancements in machine learning and AI. 💡   During the ‘AI for Science - Scaling in AI for Scientific Discovery’ workshop on Friday 26 Jul, 9:00 a.m. - 5:00 p.m. CEST, BioMap’s CTO Le Song will be presenting our latest research on “Training Compute-Optimal Protein Language Models”. This research, which involved extensive training of over 300 models, has yielded significant insights into the relationship between model size, training data, and performance.   The study introduces a novel approach to address the issue of overfitting and performance plateaus in PLMs by utilizing a vast dataset of 194 billion unique tokens from 939 million protein sequences. It reveals distinct scaling laws for both masked language modelling (MLM) and causal language modelling (CLM), demonstrating the effectiveness of transferring knowledge from CLM to MLM through scaling behaviours.   ✅ Sign up for the workshop here: https://lnkd.in/gcAfyWnW   #MachineLearning #ML #AI #ArtificialIntelligence #Science #Technology #Innovation #BioMap #ICML [ICML] Int'l Conference on Machine Learning

High-performing protein prediction models can potentially enable more accurate, efficient, and innovative drug development workflows💊💉 While AlphaFold3 is often considered to be the industry performance benchmark, a new comparison study has demonstrated that there are alternative approaches to the application of AI in protein design that can yield equally impressive or even superior performance. The study compared xTrimoDock, the antibody docking prediction model from BioMap, to Google DeepMind’s new AlphaFold 3. Preliminary results have shown that xTrimo outperforms AlphaFold 3 in its accuracy in predicting the structure and binding of selected proteins, including antibodies and other biotherapeutics, with their targets ⚙️🧬 Contact us to learn more.

We’re excited to announce the launch of the BioMap Bio-Computing Innovation Accelerator Program – BioMap BioX. This beneficial initiative will nurture local scientific innovation teams and attract global innovators, starting from Hong Kong, to promote the development of the global AI for life science ecosystem. BioX will focus on four key industries: - Pharmaceuticals and health - Green technology - Industrial innovation - Consumer product innovation Are you a researcher, scientist or entrepreneur in these fields? In this unique programme, you will be able to take advantage of BioMap’s expert technical support and build connections with global companies and investors in the life sciences and bio-computing sectors. Don’t miss this valuable opportunity to fast-track your project’s transition from early-stage research to marketable products and industrial-scale companies. Apply here: https://buff.ly/3VS90sU

Our platform makes a wide range of AI models available to customers to utilise for optimisation of their biologics. In addition, customers can upload their own data to the platform to further fine-tune the models for their own research – creating custom models that benefit from the extensive data held within our large language models. #Technology #Innovation #AI #data #LargeLanguageModels #Research

We are delighted to announce that the Hong Kong Investment Corporation Limited (HKIC) has signed a strategic partnership agreement with BioMap, underscoring a significant commitment to transforming Hong Kong into a leading international bio-computing innovation hub. The strategic partnership agreement was signed by Ms Clara Chan, CEO of HKIC, and Mr Wei Liu, Co-Founder and CEO of BioMap, witnessed by Mr Paul Chan Mo-po, Financial Secretary of the Hong Kong SAR Government, during a ceremony at the inaugural "International Bio-Computing Innovation Summit" on Monday 24th June. #BioComputing #AI #LifeSciences

On Monday 24th June, BioMap hosted the first "International Bio-Computing Innovation Summit" in Hong Kong. The event featured keynote speeches and panel discussions with industry experts, including senior executives from multinational pharmaceutical companies Sanofi and Eli Lilly China, green technology companies LanzaTech and Syngenta, and an academic expert from Rutgers University, USA. We enjoyed sessions covering a wide range of fascinating topics, such as accelerating new drug development to improve human health and advancing green technology innovation for global sustainable development. Thank you to all our speakers for sharing your expertise and insights! Maria Wendt, Marilene Pavan, Kevin Donohue, Ryan Wang, Sagar Khare, Wei LIU, Per Jr. Greisen & Le Song. And thanks to all our partners, supporters and attendees – we hope to see you all again soon! #BioComputing #AI #LifeSciences